Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a new drug help hearts heal? study investigates vericiguat for heart failure

NCT ID NCT07405944

Recruiting now Disease control Sponsor: University Medical Centre Ljubljana Source: ClinicalTrials.gov ↗

First seen Feb 12, 2026 · Last updated May 24, 2026 · Updated 14 times

Summary

This study looks at whether the drug vericiguat can improve heart function in adults with stable heart failure with reduced ejection fraction (HFrEF). About 60 participants will either take vericiguat plus their usual medications or just their usual medications. Researchers will use heart scans and blood tests over 12 months to see if vericiguat helps the heart pump better and reduces damage.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Medical Centre Ljubljana

    RECRUITING

    Ljubljana, 1000, Slovenia

    Contact Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

CHRONIC HEART FAILURE HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)